NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

17 hedge funds and large institutions have $1.17M invested in InVivo Therapeutics Holdings Corp in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1
+$288K
2
+$266K
3
+$200K
4
SCM
Stonepine Capital Management
Oregon
+$132K
5
AFM
Anson Funds Management
Texas
+$93K

Top Sellers

1
-$143K
2
-$123K
3
-$52K
4
RJA
Raymond James & Associates
Florida
-$40K
5
TSS
Two Sigma Securities
New York
-$40K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
1
2